These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38714473)

  • 1. Short-term effect of gluten-free diet on disease severity, quality of life, and inflammatory markers among patients with mild to moderate ulcerative colitis: A triple-blind randomized placebo-controlled trial.
    Alborzi Avanaki F; Ebrahimi Daryani N; Aletaha N; Hesabgar N; Rezaee-Zavareh MS; Hadi R
    Arab J Gastroenterol; 2024 May; ():. PubMed ID: 38714473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis for the treatment of ulcerative colitis.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of biological interventions for ulcerative colitis on health-related quality of life.
    LeBlanc K; Mosli MH; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD008655. PubMed ID: 26393522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Melatonin as an Adjunctive Therapy on Clinical, Biochemical, and Quality of Life in Patients with Ulcerative Colitis.
    Shahrokh S; Qobadighadikolaei R; Abbasinazari M; Haghazali M; Asadzadeh Aghdaei H; Abdi S; Balaii H; Khanzadeh-Moghaddam N; Zali MR
    Iran J Pharm Res; 2021; 20(2):197-205. PubMed ID: 34567156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of coenzyme Q10 on health-related quality of life, clinical disease activity and blood pressure in patients with mild to moderate ulcerative colitis: a randomized clinical trial.
    Farsi F; Ebrahimi-Daryani N; Barati M; Janani L; Karimi MY; Akbari A; Irandoost P; Mesri Alamdari N; Agah S; Vafa M
    Med J Islam Repub Iran; 2021; 35():3. PubMed ID: 33996654
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.
    Surti B; Spiegel B; Ippoliti A; Vasiliauskas EA; Simpson P; Shih DQ; Targan SR; McGovern DP; Melmed GY
    Dig Dis Sci; 2013 May; 58(5):1313-21. PubMed ID: 23250673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial.
    Kedia S; Virmani S; K Vuyyuru S; Kumar P; Kante B; Sahu P; Kaushal K; Farooqui M; Singh M; Verma M; Bajaj A; Markandey M; Sachdeva K; Das P; Makharia GK; Ahuja V
    Gut; 2022 Dec; 71(12):2401-2413. PubMed ID: 35973787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis.
    Sadeghi N; Mansoori A; Shayesteh A; Hashemi SJ
    Phytother Res; 2020 May; 34(5):1123-1133. PubMed ID: 31802559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis.
    Farsi F; Ebrahimi-Daryani N; Golab F; Akbari A; Janani L; Karimi MY; Irandoost P; Alamdari NM; Agah S; Vafa M
    Eur J Nutr; 2021 Sep; 60(6):3397-3410. PubMed ID: 33620550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.
    Bennebroek Evertsz' F; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA
    J Crohns Colitis; 2013 Dec; 7(11):890-900. PubMed ID: 23269224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial.
    Khazdouz M; Daryani NE; Cheraghpour M; Alborzi F; Hasani M; Ghavami SB; Shidfar F
    Eur J Nutr; 2023 Dec; 62(8):3125-3134. PubMed ID: 37525068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life in Newly Diagnosed Moderate-to-Severe Ulcerative Colitis: Changes in the MOSAIK Cohort Over 1 Year.
    Jo IH; Lee KM; Kim DB; Kim JW; Lee J; Jeen YT; Kim TO; Kim JS; Park JJ; Hong SN; Park DI; Kim HS; Lee YJ; Kim Y
    Gut Liver; 2022 May; 16(3):384-395. PubMed ID: 34373363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy of Thymus kotschyanus extract as an additive treatment in patients with ulcerative colitis: a randomized double-blind placebo-controlled trial.
    Vazirian F; Samadi S; Abbaspour M; Taleb A; Bagherhosseini H; Mozaffari HM; Mohammadpour AH; Emami SA
    Inflammopharmacology; 2022 Dec; 30(6):2145-2152. PubMed ID: 35723850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status.
    Karimi S; Tabataba-Vakili S; Yari Z; Alborzi F; Hedayati M; Ebrahimi-Daryani N; Hekmatdoost A
    Nutr J; 2019 Mar; 18(1):16. PubMed ID: 30871542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis.
    Xiang JY; Ouyang Q; Li GD; Xiao NP
    World J Gastroenterol; 2008 Jan; 14(1):53-7. PubMed ID: 18176961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial.
    Shen Z; Zheng K; Zou J; Gu P; Xing J; Zhang L; Zhu L; Shen H
    Trials; 2021 Jan; 22(1):55. PubMed ID: 33441157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
    Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
    Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.
    Sadeghi O; Milajerdi A; Siadat SD; Keshavarz SA; Sima AR; Vahedi H; Adibi P; Esmaillzadeh A
    Trials; 2020 Jun; 21(1):565. PubMed ID: 32576228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.